(Q42128608)

17 October 2017

Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition (English)

1 reference

17 October 2017

Marti JH

1

1 reference

17 October 2017

Thomson DM

series ordinal

2

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 August 1976

1 reference

British Journal of Cancer

17 October 2017

1 reference

17 October 2017

34

1 reference

17 October 2017

2

1 reference

17 October 2017

116-133

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1976.134

17 October 2017

0 references

cites work

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Tumour-specific Antibodies in Human Malignant Melanoma and their Relationship to the Extent of the Disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Cell-Mediated Immunity and Specific Serum Factors in Human Cancer: The Leukocyte Adherence Inhibition Test2

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Cytotoxic lymphocytes in melanoma patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Antibodies and Soluble Tumour-specific Antigens in Blood and Lymph of Rats with Chemically Induced Sarcomata

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Antigen-mediated macrophage adherence inhibition

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Clinical and immunological significance of human melanoma cytotoxic antibody

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Immunodepression after major surgery in normal patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Immunologically-mediated restraint of latent tumour metastases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Soluble tumour-specific antigen and its relationship to tumour growth

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Soluble membrane antigens of human malignant melanoma cells.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2025156

Cancer cells in the blood; a five to nine year follow up study

17 August 2018

1 reference

12 December 2020

Some recent studies on cellular immunity to human melanomas.

1 reference

12 December 2020

Batch preparation of rabbit gammaG globulin with deae-cellulose

1 reference

12 December 2020

Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection

1 reference

12 December 2020

Characterization of glass adherent human mononuclear cells

1 reference

12 December 2020

Anti-tumor immunoreactivity in patients with malignant melanoma

1 reference

12 December 2020

Carcinoma of the colon and rectum: Circulating malignant cells and five-year survival

1 reference

12 December 2020

Cellular and humoral immunity against human malignant melanoma

1 reference

12 December 2020

Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

1 reference

12 December 2020

Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes

1 reference

12 December 2020

Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells

1 reference

12 December 2020

Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1976.134

1 reference

Dimensions Publication ID

17 October 2017

0 references

1 reference

17 October 2017

PubMed publication ID

962991

1 reference